BUENA, N.J., Feb. 27, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced its financial results for the fourth quarter and year ended December 31, 2013.
Fourth Quarter and Year to Date 2013 Highlights
•Total revenues of $6.7 million in the fourth quarter of 2013, an increase of 191% over the same quarter in 2012
Help employers find you! Check out all the jobs and post your resume.
